Geninus (지니너스)
Seoul, South Korea
Geninus (지니너스) uses big data analysis for genomics, with solutions in liquid biopsy, cancer genomics, risk prediction of chronic diseases, personalized weight management and more. The company has built a database of cancer gene mutation frequencies, by utilizing over 150,000 public genome databases and over 15,000 clinical specimen databases obtained in partnership with Samsung Medical Center. Core technologies by Geninus include bidirectional sequencing, CNV mutation detection, fusion mutation detection, SNV/indel mutation detection, and MSI/TMB mutation detection.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2018
- Website
- geninustx.com/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Geninus (지니너스)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now